Pneumonia, Mycoplasma

Letter to the Editor
In Vitro Activity of a New Quinoline Derivative, ER-2, against Clinical Isolates of Mycoplasma pneumoniae and Mycoplasma hominis
Shilpakala Sainath Rao, Raghavachari Raghunathan, Ramesh Ekambaram, Malathi Raghunathan
Experimental Therapeutics
Tigecycline Therapy Significantly Reduces the Concentrations of Inflammatory Pulmonary Cytokines and Chemokines in a Murine Model of Mycoplasma pneumoniae Pneumonia
C. M. Salvatore, C. Techasaensiri, C. Tagliabue, K. Katz, N. Leos, A. M. Gomez, G. H. McCracken, R. D. Hardy
Mechanisms of Resistance
Increased Macrolide Resistance of Mycoplasma pneumoniae in Pediatric Patients with Community-Acquired Pneumonia
Miyuki Morozumi, Satoshi Iwata, Keiko Hasegawa, Naoko Chiba, Reiko Takayanagi, Keita Matsubara, Eiichi Nakayama, Keisuke Sunakawa, Kimiko Ubukata
and the Acute Respiratory Diseases Study Group
Experimental Therapeutics
Evaluation of LBM415 (NVP PDF-713), a Novel Peptide Deformylase Inhibitor, for Treatment of Experimental Mycoplasma pneumoniae Pneumonia
Monica Fonseca-Aten, Christine M. Salvatore, Asunción Mejías, Ana M. Ríos, Susana Chávez-Bueno, Kathy Katz, Ana M. Gómez, George H. McCracken, R. Doug Hardy
Experimental Therapeutics
Microbiologic and Immunologic Evaluation of a Single High Dose of Azithromycin for Treatment of Experimental Mycoplasma pneumoniae Pneumonia
Ana María Ríos, Mónica Fonseca-Aten, Asunción Mejías, Susana Chávez-Bueno, Kathy Katz, Ana María Gómez, George H. McCracken, Octavio Ramilo, R. Doug Hardy
Mechanisms of Resistance
Characterization and Molecular Analysis of Macrolide-Resistant Mycoplasma pneumoniae Clinical Isolates Obtained in Japan
Mayumi Matsuoka, Mitsuo Narita, Norio Okazaki, Hitomi Ohya, Tsutomu Yamazaki, Kazunobu Ouchi, Isao Suzuki, Tomoaki Andoh, Tsuyoshi Kenri, Yuko Sasaki, Atsuko Horino, Miharu Shintani, Yoshichika Arakawa, Tsuguo Sasaki
Susceptibility
In Vitro Susceptibilities of Mycoplasma hyopneumoniae Field Isolates
J. Vicca, T. Stakenborg, D. Maes, P. Butaye, J. Peeters, A. de Kruif, F. Haesebrouck
Experimental Therapeutics
Impact of Cethromycin (ABT-773) Therapy on Microbiological, Histologic, Immunologic, and Respiratory Indices in a Murine Model of Mycoplasma pneumoniae Lower Respiratory Infection
Ana María Ríos, Asunción Mejías, Susana Chávez-Bueno, Mónica Fonseca-Aten, Kathy Katz, Jeanine Hatfield, Ana María Gómez, Hasan S. Jafri, George H. McCracken, Octavio Ramilo, Robert Doug Hardy
Experimental Therapeutics
Antimicrobial and Immunologic Activities of Clarithromycin in a Murine Model of Mycoplasma pneumoniae-Induced Pneumonia
Robert D. Hardy, Ana Maria Rios, Susana Chavez-Bueno, Hasan S. Jafri, Jeanine Hatfield, Beverly B. Rogers, George H. McCracken, Octavio Ramilo
Experimental Therapeutics
In Vitro and In Vivo Efficacies of T-3811ME (BMS-284756) against Mycoplasma pneumoniae
Masahiro Takahata, Masako Shimakura, Ritsuko Hori, Kazuo Kizawa, Yozo Todo, Shinzaburo Minami, Yasuo Watanabe, Hirokazu Narita

Main menu

User menu

Search

Pneumonia, Mycoplasma